Outro Raises $7 Million To Expand Deprescribing Platform Beyond Antidepressants
By Amit Chowdhry ● Oct 8, 2026
Outro, a New York-based healthcare company focused on helping patients discontinue psychiatric medications, has raised $7 million across pre-seed and seed rounds to expand its deprescribing platform, grow its clinician network, develop AI-supported workflows, and expand into additional medication categories. The financing included participation from Listen Ventures, Cake Ventures, Jason Calacanis’s LAUNCH, Actions Capital, Hannah Grey Ventures, SemperVirens, Brock Recovery Group, and Pave Health Ventures, as well as additional investors.